HRD

About

Biomarker type: Homologous recombination

Status: Deficient

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations Biomarkers Cancer types Therapies
FDA (1) HRD Ovarian Epithelial Tumor Bevacizumab, Olaparib
FDA (1) HRD High-Grade Serous Fallopian Tube Cancer Bevacizumab, Olaparib
FDA (1) HRD Peritoneal Serous Carcinoma Bevacizumab, Olaparib